Dangers of banning Spice and the synthetic cannabinoid agonists

Richard Hammersley

    Research output: Contribution to journalLetter

    Abstract

    Due to the use of Spice and similar products comprising herbal mixture sprayed with synthetic cannabinoid agonists [1], the UK Advisory Council on the Misuse of Drugs (ACMD), following some other countries, is advising that a range of synthetic cannabinoids become controlled drugs [2]. This makesmedical sense, because the effects of these chemicals are untested, unknown and some of
    them may be dangerous. Moreover, banning dangerous pharmaceuticals has sometimes reduced use and harm in the past, for instance with gel formulation temazepam and barbiturates. Will this work when the drugs to be banned are being sold only because the ‘safer’ equivalent—cannabis—is not licensed in the United Kingdom for medical (or recreational) use and was re-classified recently as more dangerous against the advice of the ACMD?

    Original languageEnglish
    Pages (from-to)373
    Number of pages1
    JournalAddiction
    Volume105
    Issue number2
    DOIs
    Publication statusPublished - 1 Feb 2010

    Fingerprint

    Cannabinoid Receptor Agonists
    Spices
    Pharmaceutical Preparations
    Barbiturates
    Temazepam
    Cannabinoids
    Gels

    Keywords

    • cannabis
    • synthetic cannabinoids
    • health pyschology

    Cite this

    Hammersley, Richard. / Dangers of banning Spice and the synthetic cannabinoid agonists. In: Addiction. 2010 ; Vol. 105, No. 2. pp. 373.
    @article{9c3b9a26a2b542a1bc0648b7e7efce6e,
    title = "Dangers of banning Spice and the synthetic cannabinoid agonists",
    abstract = "Due to the use of Spice and similar products comprising herbal mixture sprayed with synthetic cannabinoid agonists [1], the UK Advisory Council on the Misuse of Drugs (ACMD), following some other countries, is advising that a range of synthetic cannabinoids become controlled drugs [2]. This makesmedical sense, because the effects of these chemicals are untested, unknown and some of them may be dangerous. Moreover, banning dangerous pharmaceuticals has sometimes reduced use and harm in the past, for instance with gel formulation temazepam and barbiturates. Will this work when the drugs to be banned are being sold only because the ‘safer’ equivalent—cannabis—is not licensed in the United Kingdom for medical (or recreational) use and was re-classified recently as more dangerous against the advice of the ACMD?",
    keywords = "cannabis, synthetic cannabinoids, health pyschology",
    author = "Richard Hammersley",
    note = "<p>Letter originally published in: Addiction (2010), 105 (2), p.373.</p>",
    year = "2010",
    month = "2",
    day = "1",
    doi = "10.1111/j.1360-0443.2009.02845.x",
    language = "English",
    volume = "105",
    pages = "373",
    journal = "Addiction",
    issn = "0965-2140",
    number = "2",

    }

    Dangers of banning Spice and the synthetic cannabinoid agonists. / Hammersley, Richard.

    In: Addiction, Vol. 105, No. 2, 01.02.2010, p. 373.

    Research output: Contribution to journalLetter

    TY - JOUR

    T1 - Dangers of banning Spice and the synthetic cannabinoid agonists

    AU - Hammersley, Richard

    N1 - <p>Letter originally published in: Addiction (2010), 105 (2), p.373.</p>

    PY - 2010/2/1

    Y1 - 2010/2/1

    N2 - Due to the use of Spice and similar products comprising herbal mixture sprayed with synthetic cannabinoid agonists [1], the UK Advisory Council on the Misuse of Drugs (ACMD), following some other countries, is advising that a range of synthetic cannabinoids become controlled drugs [2]. This makesmedical sense, because the effects of these chemicals are untested, unknown and some of them may be dangerous. Moreover, banning dangerous pharmaceuticals has sometimes reduced use and harm in the past, for instance with gel formulation temazepam and barbiturates. Will this work when the drugs to be banned are being sold only because the ‘safer’ equivalent—cannabis—is not licensed in the United Kingdom for medical (or recreational) use and was re-classified recently as more dangerous against the advice of the ACMD?

    AB - Due to the use of Spice and similar products comprising herbal mixture sprayed with synthetic cannabinoid agonists [1], the UK Advisory Council on the Misuse of Drugs (ACMD), following some other countries, is advising that a range of synthetic cannabinoids become controlled drugs [2]. This makesmedical sense, because the effects of these chemicals are untested, unknown and some of them may be dangerous. Moreover, banning dangerous pharmaceuticals has sometimes reduced use and harm in the past, for instance with gel formulation temazepam and barbiturates. Will this work when the drugs to be banned are being sold only because the ‘safer’ equivalent—cannabis—is not licensed in the United Kingdom for medical (or recreational) use and was re-classified recently as more dangerous against the advice of the ACMD?

    KW - cannabis

    KW - synthetic cannabinoids

    KW - health pyschology

    U2 - 10.1111/j.1360-0443.2009.02845.x

    DO - 10.1111/j.1360-0443.2009.02845.x

    M3 - Letter

    VL - 105

    SP - 373

    JO - Addiction

    JF - Addiction

    SN - 0965-2140

    IS - 2

    ER -